You are here

cancer

Where Will Eli Lilly Be in 5 Years?

Motley Fool

Sun, 03/2/25 - 09:41 pm

ulcerative colitis

NeOnc: bypassing the blood-brain barrier in brain cancer

Clinical Trials Arena

Fri, 02/28/25 - 11:15 am

internasal drug delivery

blood-brain barrier

Perlmutter's Eikon raises $351m in major financing round

Pharmaphorum

Wed, 02/26/25 - 09:58 am

Eikon Therapeutics

Roger Perlmutter

VA and HHS Object to Johnson & Johnson Talc Cancer Plan

Mesothelioma Guide

Sun, 02/16/25 - 07:40 pm

Otsuka breaks up with cancer candidates on strategic grounds

Fierce Biotech

Fri, 02/14/25 - 09:22 am

Amgen ends Ideaya cancer combination trial after partner unveils rival molecule

Fierce Biotech

Thu, 02/13/25 - 09:45 pm

IDEAYA Biosciences

AdvanCell, Lilly partner on new targeted alpha therapies for cancer treatment

Pharmaceutical Business Review

Tue, 02/11/25 - 11:27 am

radiopharmaceuticals

alpha radiation

Pfizer taps a former Novartis exec to lead cancer drug push

BioPharma Dive

Thu, 02/6/25 - 11:38 am

Ascentage raises $126m in first biotech IPO of 2025

Pharmaphorum

Mon, 01/27/25 - 11:15 am

Ascentage Pharma

Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.

Motley Fool

Sun, 01/26/25 - 04:13 pm

The FDA pulls key DEI initiative for cancer studies from its website

NPR

Sun, 01/26/25 - 04:06 pm

clinical trial diversity

clinical trials

Trump Administration Delays Funding To Cancer Research

Forbes

Thu, 01/23/25 - 11:13 pm

clinical trials

FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain

MSN/Reuters

Tue, 01/14/25 - 06:08 pm

Express Scripts

JPM25: Strategist GSK acquires IDRx for $1B in hopes of bringing GIST patients new standard of care

Fierce Biotech

Mon, 01/13/25 - 11:18 am

precision medicine

Lilly pads cancer drug pipeline with Scorpion deal

BioPharma Dive

Mon, 01/13/25 - 11:00 am

Scorpion Therapeutics

Trump, RFK Jr. dine with Pfizer and Lilly execs

Axios

Sun, 12/8/24 - 09:55 pm

Robert F Kennedy Jr.

Genmab expands its pipeline with $630m Scancell deal

Pharmaphorum

Wed, 12/4/24 - 10:01 am

Takeda pays Keros $200M upfront for rival to BMS' booming blockbuster Reblozyl

Fierce Biotech

Tue, 12/3/24 - 11:00 am

Keros Therapeutics

Bristol Myers Squibb

Roche to buy cell therapy developer Poseida for $1B

BioPharma Dive

Tue, 11/26/24 - 11:24 am

Poseida Therapeutics

Exact Sciences showcases early cancer detection test data at AACR meeting

Clinical Trials Arena

Fri, 11/15/24 - 11:13 am

Pages